Cutaneous manifestations of antineutrophil cytoplasmic antibody-associated vasculitis (AAV): a concise review with emphasis on clinical and histopathologic correlation - PubMed (original) (raw)

Review

. 2022 Dec;61(12):1442-1451.

doi: 10.1111/ijd.16247. Epub 2022 May 22.

Affiliations

Review

Cutaneous manifestations of antineutrophil cytoplasmic antibody-associated vasculitis (AAV): a concise review with emphasis on clinical and histopathologic correlation

Lawrence E Gibson. Int J Dermatol. 2022 Dec.

Abstract

Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) comprises a group of small vessel vasculitides grouped by commonalities of clinical manifestations and ANCA testing. Skin findings are not uncommon, although there is considerable overlap and many times nonspecificity. In general, patients with skin findings tend to have more significant systemic illness, and skin lesions most often develop simultaneously or following onset of systemic symptoms. There are clinical and pathological clues of help in the differentiation of skin findings in these disorders. Purpura of various forms with leukocytoclastic vasculitis is common to all AAV. Granulomatosis with polyangiitis (GPA) comprises the largest number of patients with an AAV. Upper airway, oral, ear, and facial lesions, with or without granuloma, are more commonly seen in this AAV. Pyoderma gangrenosum-like lesions, including facial location, while not common are most closely associated with GPA. Eosinophilic granulomatosis with polyangiitis (EGPA) as its name implies is more closely associated with eosinophilic, allergic, or asthmatic conditions. Papular lesions of the extensor extremities showing extravascular granulomatous changes are characteristic but not specific for EGPA. Microscopic polyangiitis (MPA) is more closely associated with livedoid skin changes, and vascular inflammation tends to be deeper in the skin than with the other AAV. Extravascular granulomas are not expected. While the skin findings in AAV can be nonspecific and overlapping, combining careful full skin examination with histopathologic study of selected lesions is critical to making the correct diagnosis and in ruling out other similar diseases not ANCA related. The aim of this article is to encourage increased participation by dermatologists and dermatopathologists in the care of these patients.

Keywords: ANCA-associated vasculitis (AAV); cutaneous vasculitis; eosinophilic granulomatosis with polyangiitis (EGPA); granulomatosis with polyangiitis (GPA); microscopic polyangiitis (MPA); pyoderma gangrenosum (PG).

© 2022 the International Society of Dermatology.

PubMed Disclaimer

Similar articles

References

    1. Jennette JC, Falk RJ, Bacon PA, et al. Revised international Chapel Hill consensus conference nomenclature of vasculitides. 2013. Arthritis Rheum 2012; 65: 1-11.
    1. Frumholtz L, Laurent-Roussel S, Aumaitre O, et al. Clinical and pathological significance of cutaneous manifestations in ANCA-associated vasculitis. Autoimmun Rev 2017; 16: 1138-1146.
    1. Micheletti RG, Fuxeuch ZC, Craven A, et al. Cutaneous manifestations of antineutrophil cytoplasmic antibody-associated vasculitis. Arthr Rheumatol 2020; 72: 1741-1747.
    1. Gibson LE, Specks U, Homburger H. Clinical utility of ANCA tests for the dermatologist. Int J Dermatol 2003; 42: 859-869.
    1. Marzano AV, Raimondo MG, Berti E, et al. Cutaneous manifestations of ANCA-associated small vessels vasculitis. Clin Rev Allergy Immunol 2017; 53: 428-438.

Publication types

MeSH terms

Substances

LinkOut - more resources